BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25359393)

  • 21. Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a National Registry and Multicenter Cohort Study.
    Haugen CE; Thomas AG; Chu NM; Shaffer AA; Norman SP; Bingaman AW; Segev DL; McAdams-DeMarco M
    Am J Transplant; 2020 Apr; 20(4):1170-1180. PubMed ID: 31733176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study.
    Thorsen IS; Bleskestad IH; Åsberg A; Hartmann A; Skadberg Ø; Brede C; Ueland T; Pasch A; Reisaeter AV; Gøransson LG
    Clin Transplant; 2019 May; 33(5):e13517. PubMed ID: 30844090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited health literacy and adverse outcomes among kidney transplant candidates.
    Warsame F; Haugen CE; Ying H; Garonzik-Wang JM; Desai NM; Hall RK; Kambhampati R; Crews DC; Purnell TS; Segev DL; McAdams-DeMarco MA
    Am J Transplant; 2019 Feb; 19(2):457-465. PubMed ID: 29962069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty and Access to Kidney Transplantation.
    Haugen CE; Chu NM; Ying H; Warsame F; Holscher CM; Desai NM; Jones MR; Norman SP; Brennan DC; Garonzik-Wang J; Walston JD; Bingaman AW; Segev DL; McAdams-DeMarco M
    Clin J Am Soc Nephrol; 2019 Apr; 14(4):576-582. PubMed ID: 30890577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients.
    Osté MCJ; Gomes-Neto AW; Corpeleijn E; Gans ROB; de Borst MH; van den Berg E; Soedamah-Muthu SS; Kromhout D; Navis GJ; Bakker SJL
    Am J Transplant; 2018 Oct; 18(10):2523-2533. PubMed ID: 29464830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frailty and Changes in Cognitive Function after Kidney Transplantation.
    Chu NM; Gross AL; Shaffer AA; Haugen CE; Norman SP; Xue QL; Sharrett AR; Carlson MC; Bandeen-Roche K; Segev DL; McAdams-DeMarco MA
    J Am Soc Nephrol; 2019 Feb; 30(2):336-345. PubMed ID: 30679381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of frailty in kidney transplantation: measurement, management and future considerations.
    Harhay MN; Rao MK; Woodside KJ; Johansen KL; Lentine KL; Tullius SG; Parsons RF; Alhamad T; Berger J; Cheng XS; Lappin J; Lynch R; Parajuli S; Tan JC; Segev DL; Kaplan B; Kobashigawa J; Dadhania DM; McAdams-DeMarco MA
    Nephrol Dial Transplant; 2020 Jul; 35(7):1099-1112. PubMed ID: 32191296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of Frailty in Kidney Transplant Recipients.
    Vázquez-Sánchez T; López V; Schuldt R; Bouarich O; Arrebola A; Antúnez P; Ruiz E; Ortega L; Hernández D
    Transplant Proc; 2023 Dec; 55(10):2271-2274. PubMed ID: 37778931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes.
    Molnar MZ; Streja E; Kovesdy CP; Shah A; Huang E; Bunnapradist S; Krishnan M; Kopple JD; Kalantar-Zadeh K
    Am J Kidney Dis; 2012 Jun; 59(6):841-8. PubMed ID: 22305759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    Chancharoenthana W; Townamchai N; Pongpirul K; Kittiskulnam P; Leelahavanichkul A; Avihingsanon Y; Suankratay C; Wattanatorn S; Kittikowit W; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Transplant; 2014 Dec; 14(12):2814-20. PubMed ID: 25395260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study.
    Ruggenenti P; Silvestre C; Boschiero L; Rota G; Furian L; Perna A; Rossini G; Remuzzi G; Rigotti P
    Am J Transplant; 2017 Dec; 17(12):3159-3171. PubMed ID: 28792681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.
    McAdams-DeMarco MA; Law A; Tan J; Delp C; King EA; Orandi B; Salter M; Alachkar N; Desai N; Grams M; Walston J; Segev DL
    Transplantation; 2015 Apr; 99(4):805-10. PubMed ID: 25393156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Benefit From Kidney Transplantation Using Kidneys From Deceased Donors Aged ≥75 Years: A Time-Dependent Analysis.
    Pérez-Sáez MJ; Arcos E; Comas J; Crespo M; Lloveras J; Pascual J;
    Am J Transplant; 2016 Sep; 16(9):2724-33. PubMed ID: 27004984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis.
    McAdams-DeMarco MA; Law A; Salter ML; Boyarsky B; Gimenez L; Jaar BG; Walston JD; Segev DL
    J Am Geriatr Soc; 2013 Jun; 61(6):896-901. PubMed ID: 23711111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation.
    Yunhua T; Qiang Z; Lipeng J; Shanzhou H; Zebin Z; Fei J; Zhiheng Z; Linhe W; Weiqiang J; Dongping W; Zhiyong G; Xiaoshun H
    Transplant Proc; 2018; 50(1):202-210. PubMed ID: 29407310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.
    Bae S; Massie AB; Thomas AG; Bahn G; Luo X; Jackson KR; Ottmann SE; Brennan DC; Desai NM; Coresh J; Segev DL; Garonzik Wang JM
    Am J Transplant; 2019 Feb; 19(2):425-433. PubMed ID: 29935051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.
    Locke JE; Shelton BA; Reed RD; MacLennan PA; Mehta S; Sawinski D; Segev DL
    Am J Transplant; 2016 Aug; 16(8):2377-83. PubMed ID: 27140837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.
    Foster MC; Weiner DE; Bostom AG; Carpenter MA; Inker LA; Jarolim P; Joseph AA; Kusek JW; Pesavento T; Pfeffer MA; Rao M; Solomon SD; Levey AS
    Am J Transplant; 2017 Sep; 17(9):2390-2399. PubMed ID: 28257169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does age affect the outcome of kidney transplantation in elderly recipients?
    Neri F; Furian L; Cavallin F; Ravaioli M; Silvestre C; Donato P; La Manna G; Pinna AD; Rigotti P
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28640530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.